OPIS is an international CRO founded in Italy in 1998.
In its 21 years of activity, OPIS has expanded beyond national borders and is currently represented all over EU. OPIS provides full-service support in the management of multi-country clinical drug and medical device trials in the majority of therapeutic areas that include oncology, immuno-oncology, neurology and rare disease indications and other personalized targeted therapies.
OPIS covers all aspects of clinical trial management: medical writing from concept sheet and full protocol writing up to the final study report, clinical operations including project management and monitoring, regulatory and trial-start up activities and pharmacovigilance; either with a full-service approach or managing individual or part of the activities, depending on Sponsor’s requirements. OPIS also provides eClinical services designed to safely streamline the execution of each project, and the Company Biometrics Department works in close collaboration with the Clinical IT Staff to provide state-of-the-art e-clinical solutions including a proprietary EDC system (Clinical.net) and study portal.